Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial The economic evaluation, conducted from societal ...

Older patients are heterogeneous, and tailoring cancer treatment to the individual requires weighing risks against benefits in the context of frailty, which is best assessed through geriatric ...

Although concurrent chemoradiotherapy (cCRT) increases survival in patients with inoperable, locally advanced non-small-cell lung cancer (NSCLC), there is no consensus on the treatment of elderly ...

Telehealth geriatric assessment significantly improved short-term outcomes for older adults with advanced cancers. Brazilian study showed better physical function, psychological status, and quality of ...

Although comorbidities are identified in routine oncology practice, intervention plans for the coexisting needs of older people receiving chemotherapy are rarely made. This study evaluates the impact ...